Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM
NCT05417841
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
218
Enrollment
OTHER_GOV
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Insulin Degludec and Insulin Aspart Injection
DRUG:
Insulin Aspart Injection
Sponsor
Beijing Hospital